Skip to content

Exelixis

US · EXEL #1156 by market cap Listed 1970
64.63 -1.20 -1.82%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Exelixis

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Founded
1994
CEO
Dr. Michael M. Morrissey, PhD
Employees
4,600
Headquarters
Alameda, California, United States of America
Fiscal year end
01-01
Website
exelixis.com

Company profile

Exchange
US
Symbol
EXEL
Market-cap rank
#1156
Listing date
1970-01-01
Market cap
15.77B
Float cap
13.56B
Shares out
244.01M
Float shares
209.78M

Sectors & themes

Biotechnology Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:41 · For reference only, not investment advice and not tailored to your situation.

Exelixis discussion 0 comments

Add a comment